{"blog_url":"https://appleqq.hatenablog.com/","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fappleqq.hatenablog.com%2Fentry%2F2021%2F01%2F16%2F130000\" title=\"\u75c7\u4f8b68\uff1a\u53e3\u8154\u304a\u3088\u3073\u9670\u90e8\u6f70\u760d\u3001\u6392\u5c3f\u969c\u5bb3\u3001\u773c\u75db\u306a\u3069\u3067\u53d7\u8a3a\u3057\u305f20\u6b73\u7537\u6027\uff08Ann Emerg Med. 2021 Jan;77(1):46-75.\uff09 - \u308a\u3093\u3054\u306e\u8857\u306e\u6551\u6025\u533b\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","url":"https://appleqq.hatenablog.com/entry/2021/01/16/130000","author_url":"https://blog.hatena.ne.jp/AppleQQ/","published":"2021-01-16 13:00:00","blog_title":"\u308a\u3093\u3054\u306e\u8857\u306e\u6551\u6025\u533b","image_url":"https://cdn-ak.f.st-hatena.com/images/fotolife/A/AppleQQ/20210114/20210114104736.png","categories":["case study","\u6551\u6025\u7dcf\u8ad6\u30fb\u8a3a\u65ad\u6226\u7565"],"author_name":"AppleQQ","type":"rich","width":"100%","height":"190","provider_url":"https://hatena.blog","title":"\u75c7\u4f8b68\uff1a\u53e3\u8154\u304a\u3088\u3073\u9670\u90e8\u6f70\u760d\u3001\u6392\u5c3f\u969c\u5bb3\u3001\u773c\u75db\u306a\u3069\u3067\u53d7\u8a3a\u3057\u305f20\u6b73\u7537\u6027\uff08Ann Emerg Med. 2021 Jan;77(1):46-75.\uff09","provider_name":"Hatena Blog","version":"1.0","description":"\u75c5\u6b74/\u8eab\u4f53\u6240\u898b \u30fb20\u6b73\u7537\u6027 \u30fb\u53e3\u8154\u304a\u3088\u3073\u9670\u90e8\u6f70\u760d\u3001\u6392\u5c3f\u969c\u5bb3\u3001\u7d50\u819c\u5145\u8840\u3001\u8179\u90e8\u9055\u548c\u611f\u306e\u305f\u3081\uff25R\u53d7\u8a3a \u30fb\u4e0a\u6c17\u9053\u708e\u306b\u7d9a\u767a\u3057\u3066\u4e0a\u8a18\u75c7\u72b6\u304c\u51fa\u73fe\u3057\u300140\u5ea6\u306e\u767a\u71b1\u3082\u3042\u3063\u305f\u3068\u8a71\u3059 \u30fb13\u5e74\u9593\u306b\u308f\u305f\u308a\u3001\u7c98\u819c\u6f70\u760d/\u773c\u7403\u7d50\u819c\u5145\u8840/\u6d41\u6d99/\u767a\u71b1\u306e\u30a8\u30d4\u30bd\u30fc\u30c9\u304c18\u30ab\u6708\u3054\u3068\u306b\u8a8d\u3081\u3089\u308c\u3066\u3044\u305f\u3068\u3044\u3046 \u75bc\u75db\u3092\u4f34\u3046\u53e3\u8154\u5185\u6f70\u760d \u9670\u90e8\u6f70\u760d \u53f3\u773c\u5f37\u819c/\u7d50\u819c\u5145\u8840\u3002\u5f37\u819c\u708e\u306e\u6240\u898b\u3002 \u8a3a\u65ad Beh\u00e7et's disease \u30fb\u30d9\u30fc\u30c1\u30a7\u30c3\u30c8\u75c5\u306f\u518d\u767a\u3068\u5bdb\u89e3\u3092\u7279\u5fb4\u3068\u3059\u308b\u591a\u81d3\u5668\u969c\u5bb3\u3092\u5448\u3059\u308b\u75be\u60a3\u3067\u3042\u308b \u30fb\u539f\u56e0\u306f\u3042\u3089\u3086\u308b\u5f84\u306e\u52d5\u9759\u8108\u3078\u306e\u81ea\u5df1\u514d\u75ab\u6027\u8840\u7ba1\u708e\u3067\u3042\u308b\u3068\u8003\u3048\u3089\u308c\u3066\u3044\u308b \uff08Ocul Immunol Inflamm. 2012 Oct;20(5):324-\u2026"}